Overview
Glenohumeral osteoarthritis (OA) is a degenerative joint disease that affects the ball‑and‑socket joint of the shoulder—the glenohumeral joint. Over time the smooth cartilage that lines the humeral head and the glenoid cavity wears away, leading to pain, stiffness, and loss of motion.
- Who it affects: Adults over 50 are most commonly diagnosed, but younger adults can develop the condition after a significant shoulder injury or repetitive overuse.
- Prevalence: Shoulder OA accounts for roughly 10–15 % of all osteoarthritis cases worldwide. In the United States, an estimated 22 % of adults aged ≥60 have shoulder OA, and the prevalence rises to >30 % in people with a history of rotator‑cuff tears.
The condition progresses slowly, often over years, and may be unilateral (one shoulder) or bilateral.
Symptoms
Symptoms can be subtle at first and become more pronounced as cartilage loss advances.
- Joint pain: Typically a dull ache that worsens with overhead activities, reaching behind the back, or lifting objects.
- Morning stiffness: Stiffness lasting <15–30 minutes after waking; improves with gentle movement.
- Reduced range of motion: Difficulty raising the arm above shoulder level (abduction) or rotating the arm (external/internal rotation).
- Crepitus: A grinding or popping sensation felt or heard when moving the shoulder.
- Weakness: Often secondary to pain inhibition or concurrent rotator‑cuff dysfunction.
- Night pain: Discomfort that disrupts sleep, especially when lying on the affected side.
- Swelling or effusion: Fluid buildup within the joint capsule in later stages.
Causes and Risk Factors
Glenohumeral OA is multifactorial. The main driver is mechanical wear and tear, but several other contributors increase susceptibility.
Primary causes
- Age‑related cartilage degeneration: Chondrocyte (cartilage cell) function declines with age, reducing the ability to repair wear.
- Post‑traumatic changes: Prior fractures, dislocations, or severe rotator‑cuff tears accelerate cartilage loss.
- Genetic predisposition: Family history of OA raises risk, likely through inherited cartilage matrix characteristics.
Risk factors
- Age ≥ 50 years
- Male sex (slightly higher prevalence, though women often report more pain)
- Obesity – excess body mass increases systemic inflammation and mechanical load.
- Occupational overhead work (e.g., painters, electricians, athletes)
- Repetitive shoulder motion (swimming, tennis, baseball pitching)
- Previous shoulder surgery or injection therapy
- Systemic inflammatory diseases (e.g., rheumatoid arthritis) that can coexist with OA.
Diagnosis
Diagnosis is clinical, supported by imaging and occasionally laboratory tests to rule out other conditions.
History & physical exam
- Detailed symptom chronology, activity‑related pain patterns, and functional limitations.
- Inspection for deformity or swelling.
- Palpation for tenderness over the anterior, lateral, or posterior shoulder.
- Range‑of‑motion testing (active & passive) and strength assessment of the rotator cuff.
- Special tests (e.g., Neer, Hawkins‑Kennedy) to differentiate impingement from OA.
Imaging studies
- Plain radiographs: Anteroposterior (AP) “Grashey” view, scapular Y view, and axillary lateral. Look for joint space narrowing, osteophytes, subchondral sclerosis, and cysts. Sensitivity for early OA is limited.
- Magnetic Resonance Imaging (MRI): Detects cartilage thinning, labral tears, rotator‑cuff pathology, and bone edema. Recommended when symptoms are out of proportion to X‑ray findings.
- CT scan: Useful for detailed bone morphology pre‑operative planning.
Laboratory tests
Usually normal in primary OA; ordered to exclude infection, gout, or inflammatory arthritis (e.g., ESR, CRP, rheumatoid factor).
Treatment Options
Management follows a stepwise approach—from conservative measures to surgical intervention—tailored to symptom severity, functional goals, and patient health.
1. Lifestyle & Activity Modification
- Activity pacing: avoid prolonged overhead work; break tasks into short intervals.
- Ergonomic adjustments at work and home (e.g., higher shelves, assistive devices).
- Weight management: 5–10 % body‑weight loss can reduce joint load and systemic inflammation.
2. Physical Therapy & Exercise
- Range‑of‑motion exercises: Pendulum swings, wall crawls, and passive stretch to maintain mobility.
- Strengthening: Isometric rotator‑cuff and scapular stabilizer programs (e.g., Theraband external rotation, scapular retraction).
- Aerobic conditioning: Low‑impact activities such as walking or stationary cycling improve overall joint health.
- Therapist‑guided manual therapy can reduce pain and improve motion.
3. Pharmacologic Therapy
| Medication | Typical Dose | Key Considerations |
|---|---|---|
| Acetaminophen | Up to 3 g/day | First‑line for mild pain; monitor liver function. |
| NSAIDs (ibuprofen, naproxen) | Ibuprofen 400–800 mg q6‑8h | Effective for moderate pain; risk GI bleed, renal impairment. Use lowest effective dose. |
| Topical NSAIDs (diclofenac gel) | Apply 2–4 g to shoulder 3–4 times/day | Lower systemic side‑effects; good for localized pain. |
| Corticosteroid intra‑articular injection | 40–80 mg methylprednisolone | Rapid relief; limit to ≤4 injections/year to avoid cartilage toxicity. |
| Hyaluronic acid (viscosupplementation) | 5 ml intra‑articular, 1‑4 injections | Evidence modest; may improve lubrication. |
| Opioids | Low‑dose tramadol 25‑50 mg q6 h PRN | Reserved for severe refractory pain; risk dependence. |
4. Orthotic & Assistive Devices
- Shoulder slings for short‑term support after acute flare.
- Adjustable pole or reacher for retrieving items without overhead motion.
5. Interventional Procedures
- Joint aspiration: Removes excess fluid, provides diagnostic analysis.
- Platelet‑rich plasma (PRP) injections: Emerging evidence suggests modest pain reduction; still investigational.
- Radiofrequency ablation of the suprascapular nerve: Can decrease shoulder pain for 6‑12 months.
6. Surgical Options
Surgery is considered when conservative measures fail after 6–12 months and functional impairment is significant.
- Arthroscopic debridement & capsular release: Removes loose bodies and scar tissue; improves motion in early‑moderate OA.
- Total shoulder arthroplasty (TSA): Replaces humeral head and glenoid surface; indicated for advanced OA with severe pain and loss of function. 5‑year survivorship >90 % (NIH Orthopaedic Surgery Data).
- Reverse total shoulder arthroplasty (rTSA): Used when rotator‑cuff insufficiency coexists with OA; shifts the center of rotation to allow deltoid‑driven elevation.
Living with Glenohumeral Osteoarthritis
Effective self‑management can preserve function and quality of life.
Daily Tips
- Start the day with gentle shoulder stretches (e.g., pendulum, doorway stretch).
- Apply heat (warm shower or heating pad) before activity to relax muscles; use ice after activity if swelling develops.
- Incorporate low‑impact cardio (walking, swimming) to maintain overall fitness.
- Use the “pain‑first” rule: stop or modify an activity that causes sharp pain, not just mild discomfort.
- Maintain a balanced diet rich in omega‑3 fatty acids, antioxidants, and vitamin D to support joint health.
- Stay up‑to‑date with vaccinations (flu, pneumococcal) as infections can exacerbate joint inflammation.
Psychosocial Support
Chronic shoulder pain can affect mood and sleep. Consider joining a support group, practicing mindfulness, or seeking counseling if you notice depressed mood or anxiety.
Prevention
While age‑related cartilage loss is inevitable, the following measures can delay onset or progression:
- Exercise regularly: Focus on rotator‑cuff strengthening and scapular stability 2–3 times per week.
- Protect against shoulder injuries: Use proper technique in sports, wear protective gear, and address acute injuries promptly.
- Maintain a healthy weight: Reduces systemic inflammation and load on the joint.
- Ergonomic workplace: Adjust workstations to avoid excessive overhead reach.
- Vitamin D and calcium intake: Supports bone health; aim for 600‑800 IU vitamin D and 1,000 mg calcium daily (unless contraindicated).
Complications
If left untreated or inadequately managed, glenohumeral OA can lead to:
- Severe functional limitation: Inability to perform activities of daily living (e.g., dressing, bathing).
- Rotator‑cuff tear progression: Degenerative changes increase tendon vulnerability.
- Secondary frozen shoulder (adhesive capsulitis): Stiffness can become fixed, further limiting motion.
- Chronic pain syndrome: Persistent nociceptive input may lead to central sensitization.
- Joint deformity: Advanced OA may cause humeral head migration and glenoid erosion, complicating future surgery.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Sudden, severe shoulder pain after a fall or direct blow.
- Inability to move the arm at all (possible dislocation or fracture).
- Rapid swelling with a feeling of “tightness” that compromises breathing.
- Fever, chills, or red, warm skin over the shoulder—signs of possible infection.
- Sudden loss of sensation or weakness in the arm/hand (possible nerve injury).
References
- Mayo Clinic. Glenohumeral osteoarthritis. Accessed April 2026.
- Centers for Disease Control and Prevention. Arthritis Data & Statistics. 2025.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. Shoulder Osteoarthritis. 2024.
- American Academy of Orthopaedic Surgeons. Treatment of Glenohumeral Osteoarthritis. 2025 Clinical Practice Guideline.
- Cleveland Clinic. Shoulder Pain & Osteoarthritis. 2024.
- World Health Organization. Non‑communicable diseases country profiles 2023. 2024.